-
1دورية أكاديمية
المؤلفون: Gessica Della Bella, Enrico Castelli, Federico Vigevano
المصدر: Italian Journal of Pediatrics, Vol 48, Iss 1, Pp 1-3 (2022)
مصطلحات موضوعية: Sialorrhea, Glycopyrronium oral solution, Goldenhar Syndrome, Drooling Impact Scale, Modified Teachers’ Drooling Scale, Pediatrics, RJ1-570
وصف الملف: electronic resource
العلاقة: https://doaj.org/toc/1824-7288Test
-
2دورية أكاديمية
المؤلفون: A. L. Kurenkov, L. M. Kuzenkova, V. V. Chernikov, B. I. Bursagova, A. A. Nezhelskaya, A. R. Artemenko
المصدر: Неврология, нейропсихиатрия, психосоматика, Vol 13, Iss 4, Pp 52-59 (2021)
مصطلحات موضوعية: infantile cerebral palsy, sialorrhea, salivation, incobotulinumtoxina, botulinum therapy, drooling impact scale, global impression of change scale, Neurology. Diseases of the nervous system, RC346-429
وصف الملف: electronic resource
العلاقة: https://nnp.ima-press.net/nnp/article/view/1628Test; https://doaj.org/toc/2074-2711Test; https://doaj.org/toc/2310-1342Test
-
3
المؤلفون: V. V. Chernikov, L. M. Kuzenkova, A. A. Nezhelskaya, B I Bursagova, A L Kurenkov, A R Artemenko
المصدر: Nevrologiâ, Nejropsihiatriâ, Psihosomatika, Vol 13, Iss 4, Pp 52-59 (2021)
مصطلحات موضوعية: Saliva, Spastic hemiparesis, Drooling, drooling impact scale, Spastic diplegia, Spastic, Medicine, global impression of change scale, sialorrhea, RC346-429, Adverse effect, Sialorrhea, business.industry, infantile cerebral palsy, botulinum therapy, medicine.disease, Botulinum toxin, salivation, Psychiatry and Mental health, Clinical Psychology, incobotulinumtoxina, Anesthesia, Neurology. Diseases of the nervous system, Neurology (clinical), medicine.symptom, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b2702904da1323409d358a22560cc01Test
https://doi.org/10.14412/20742711-2021-4-52-59Test -
4دورية أكاديمية
المؤلفون: O. A. Klochkova, A. L. Kurenkov, H. M. Karimova, B. I. Bursagova, L. S. Namazova-Baranova, L. M. Kuzenkova, A. M. Mamedyarov, G. M. Dvoryakovskaya, О. А. Клочкова, А. Л. Куренков, Х. М. Каримова, Б. И. Бурсагова, Л. С. Намазова-Баранова, Л. М. Кузенкова, А. М. Мамедьяров, Г. М. Дворяковская
المصدر: Pediatric pharmacology; Том 12, № 4 (2015); 398-406 ; Педиатрическая фармакология; Том 12, № 4 (2015); 398-406 ; 2500-3089 ; 1727-5776
مصطلحات موضوعية: шкала GMFCS, drooling, botulinum toxin A therapy, sialorrhea, drooling impact scale, GMFCS, ultrasound-guided injections, сиалорея, слюнотечение, ботулинический токсин типа А, ботулинотерапия, Шкала оценки слюнотечения
العلاقة: Bax M., Goldstein M., Rosenbaum P., Leviton A., Paneth N., Dan B., Jacobsson B., Damiano D. Proposed definition and classifi ca tion of cerebral palsy. Dev Med Child Neurol. 2005; 47 (8): 571–576.; Johnson H., Scott A. Saliva Management. In Dysphagia: Foundation, Theory and Practice. Eds. Cichero J. A. Y., Murdoch B. F. Chichester: J Wiley & Sons, Ltd. 2006. 126 р.; Левицкий Г. Н., Алёхин А. В., Сердюк А. В., Моргунова М. С., Коне ва О. Н., Скворцова В. И. Возможности медикаментозной терапии слюнотечения при болезни двигательного нейрона. Журнал неврологии и психиатрии им. C. C. Корсакова. 2005; 105 (3): 19–22.; Blasco P. A., Allaire J. H. Drooling in the developmentally disabled: management practices and recommendations. Consortium on Drooling. Dev Med Child Neurol. 1992; 34 (10): 849–862.; Бер М., Фротшер М. Топический диагноз в неврологии по Петеру Дуусу: анатомия, физиология, клиника. Пер. с англ. Под ред. З. А. Суслиной. 4-е изд. М.: Практическая медицина. 2009. С. 163–164.; Scully C., Limeres J., Gleeson M., Tomas I., Diz P. Drooling. J Oral Pathol Med. 2009; 38 (4): 321–327.; Erasmus C. E., Van Hulst K., Rotteveel L. J., Jongerius P. H., Van Den Hoogen F. J., Roeleveld N., Rotteveel J. J. Drooling in cerebral palsy: hypersalivation or dysfunctional oral motor control? Dev Med Child Neurol. 2009; 51 (6): 454–459.; Tahmassebi J. F., Curzon M. E. The cause of drooling in children with cerebral palsy hypersalivation or swallowing defect? Int J Paediatr Dent. 2003; 13 (2): 106–111.; Dodds W. J. Physiology of swallowing. Dysphagia. 1989; 3: 171–178.; Senner J. E., Logemann J., Zecker S., Gaebler-Spira D. Drooling, saliva production, and swallowing in cerebral palsy. Dev Med Child Neurol. 2004; 46 (12): 801–806.; Tahmassebi J. F., Curzon M. E. Prevalence of drooling in children with cerebral palsy attending special schools. Dev Med Child Neurol. 2003; 45 (9): 613–617.; Parkes J., Hill N., Platt M. J., Donnelly C. Oromotor dysfunction and communication impairments in children with cerebral palsy: a register study. Dev Med Child Neurol. 2010; 52 (12): 1113–1119.; Lin Y. C., Shieh J. Y., Cheng M. L., Yang P. Y. Botulinum toxin type A for control of drooling in Asian patients with cerebral palsy. Neurology. 2008; 70 (4): 316–318.; Lakraj A. A., Moghimi N., Jabbari B. Sialorrhea: anatomy, pathophysiology and treatment with emphasis on the role of botulinum toxins. Toxins (Basel). 2013; 5 (5): 1010–1031.; Fairhurst C. B., Cockerill H. Management of drooling in children. Arch Dis Child Educ. Pract Ed. 2011; 96 (1): 25–30.; Клочкова О. А., Куренков А. Л., Намазова-Баранова Л. С., Мамедъяров А. М. Паттерны спастичности мышц верхних конечностей и применение ботулинотерапии у пациентов с детским церебральным параличом с поражением рук. Педиатрическая фармакология. 2013; 10 (5): 31–39.; Reddihough D., Erasmus C. E., Johnson H., McKellar G. M., Jon gerius P. H. Cereral Palsy Institute. Botulinum toxin assessment, intervention and aftercare for paediatric and adult drooling: international consensus statement. Eur J Neurol. 2010; 17 (Suppl. 2): 109–121.; Naumann M., So Y., Argoff C. E., Childers M. K., Dykstra D. D., Gronseth G. S., Jabbari B., Kaufmann H. C., Schurch B., Silber stein S. D., Simpson D. M. Botulinum neurotoxin in the treatment of autonomic disorders and pain (an evidence based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 2008; 70 (19): 1707–1714.; Rodwell K., Edwards P., Ware R. S., Boyd R. Salivary gland botulinum toxin injections for drooling in children with cerebral palsy and neurodevelopmental disability: a systematic review. Dev Med Child Neurol. 2012; 54 (11): 977–987.; Naumann M., Dressler D., Hallett M., Jankovic J., Schiavo G., Segal K. R., Truong D. Evidence based review and assessment of botulinum neurotoxin for the treatment of secretory disorders. Toxicon. 2013; 67: 141–152.; Walshe M., Smith M., Pennington L. Interventions for drooling in children with cerebral palsy. Cochrane Database Syst Rev. 2012; 2: CD008624. Doi:10.1002/14651858.CD008624.pub2.; Носко А. С., Зыков В. П., Комарова И. Б. Коррекция сиалореи в нейропедиатрии. Фокус на препаратах ботулинического токсина типа А как метод первого ряда выбора. Детская и подростковая реабилитация. 2013; 2 (21): 33–38.; Palisano R., Rosenbaum P. L., Walter S., Russell D., Wood E., Galuppi B. Development and reliability of a system to classify gross motor function in children with cerebral palsy. Dev Med Child Neurol. 1997; 39 (4): 214–223.; Reid S. M., Johnson H. M., Reddihough D. S. The Drooling Impact Scale: a measure of the impact of drooling in children with developmental disabilities. Dev Med Child Neurol. 2010; 52 (2): 23–28.; Reid S. M., Johnstone B. R., Westbury C., Rawicki B., Reddihough D. S. Randomized trial of botulinum toxin injections into the salivary glands to reduce drooling in children with neurological disorders. Dev Med Child Neurol. 2008; 50 (2):123–128.; Banerjee K. J., Glasson C., O’Flaherty S. J. Parotid and submandibular botulinum toxin A injections for sialorrhoea in children with cerebral palsy. Dev Med Child Neurol. 2006; 48 (11): 883–887.; Savarese R., Diamond M., Elovic E., Millis S. R. Intraparotid injection of botulinum toxin A as a treatment to control sialorrhea in children with cerebral palsy. Am J Phys Med Rehabil. 2004; 83 (4): 304–311.; Alrefai A. H., Aburahma S. K., Khader Y. S. Treatment of sialorrhea in children with cerebral palsy: a double blind placebo controlled trial. Clin Neurol Neurosurg. 2009; 111 (1): 79–82.; Lagalla G., Millevolte M., Capecci M., Provinciali L., Cera volo M. G. Botulinum toxin type A for drooling in Parkinson’s disease: a double blind, randomized, placebo controlled study. Mov Disord. 2006; 21 (5): 704–707.; Kalf J. G., Smit A. M., Bloem B. R., Zwarts M. J., Mulleners W. M., Munneke M. Botulinum toxin A for drooling in Parkinson’s disease: a pilot study to compare submandibular to parotid gland injections. Parkinsonism Relat Disord. 2007; 13 (8): 532–534.; Jongerius P. H., van den Hoogen F. J., van Limbeek J., Gabreels F. J., van Hulst K., Rotteveel J. J. Effect of botulinum toxin in the treatment of drooling: a controlled clinical trial. Pediatrics. 2004; 114 (3): 620–627.; Harris S. R., Purdy A. H. Drooling and its management in cerebral palsy. Dev Med Child Neurol. 1987; 29 (6): 807–811.; Erasmus C. E., Scheffer A. R., van Hulst K., van Limbeek J., van den Hoogen F. J., Rotteveel J. J., Jongerius P. H. Does motor perfor mance matter in botulinum toxin efficacy for drooling? Pediatr Neurol. 2011; 45 (2): 95–99.; https://www.pedpharma.ru/jour/article/view/508Test
الإتاحة: https://doi.org/10.15690/pf.v12i4.1420Test
https://doi.org/10.1002/14651858.CD008624.pub2Test
https://www.pedpharma.ru/jour/article/view/508Test -
5دورية أكاديمية
المؤلفون: Parr, Jeremy R., Weldon, Emma, Pennington, Lindsay, Steen, Nick, Williams, Jane, Fairhurst, Charlie, O'Hare, Anne, Lodh, Raj, Colver, Allan
المصدر: Parr , J R , Weldon , E , Pennington , L , Steen , N , Williams , J , Fairhurst , C , O'Hare , A , Lodh , R & Colver , A 2014 , ' The drooling reduction intervention trial (DRI) : a single blind trial comparing the efficacy of glycopyrronium and hyoscine on drooling in children with neurodisability ' , Trials , vol. 15 , 60 . https://doi.org/10.1186/1745-6215-15-60Test
مصطلحات موضوعية: Randomised trial, Drooling, Neurodisability, Glycopyrronium, Hyoscine, Children, Treatment satisfaction, Drooling impact scale, CEREBRAL-PALSY, PREVALENCE
الإتاحة: https://doi.org/10.1186/1745-6215-15-60Test
https://kclpure.kcl.ac.uk/portal/en/publications/a5dc2a1e-d65f-4e10-ab50-4777b8777028Test -
6تقرير
-
7
المؤلفون: Nick Steen, Lindsay Pennington, Charlie Fairhurst, Jeremy R. Parr, Anne O'Hare, Emma Weldon, Allan Colver, Jane Williams, Raj Lodh
المصدر: Trials
مصطلحات موضوعية: Research design, Randomised trial, medicine.medical_specialty, Time Factors, Evidence-based practice, Adolescent, Developmental Disabilities, Scopolamine, Medicine (miscellaneous), Muscarinic Antagonists, Drooling, Drooling impact scale, Cerebral palsy, law.invention, Study Protocol, Patient satisfaction, Clinical Protocols, Randomized controlled trial, law, Surveys and Questionnaires, Neurodisability, Humans, Medicine, Single-Blind Method, Pharmacology (medical), Child, Children, Treatment satisfaction, business.industry, Sialorrhea, Guideline, medicine.disease, Glycopyrrolate, Treatment Outcome, England, Patient Satisfaction, Research Design, Child, Preschool, Physical therapy, Nervous System Diseases, Glycopyrronium, medicine.symptom, Salivation, business, Hyoscine
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::09b834f3f1bda357238187d759450b53Test
https://doi.org/10.1186/1745-6215-15-60Test -
8
المؤلفون: Γρηγοροπούλου, Αντωνία, Μονιάκη, Ζαφειρία
المساهمون: Μίχου, Αιμιλία
مصطلحات موضوعية: Εγκεφαλική παράλυση, Σιελόρροια, Drooling Impact Scale, Μεθοδολογία και έρευνα
وصف الملف: application/pdf